Years before the pandemic began, airlines, logistics companies, airports and cargo handlers were working to improve their cool-chain offerings and prevent temperature excursions that could render important and valuable pharmaceutical cargo unusable. Over the years, efforts to improve airfreight’s cool-chain capabilities resulted in significant investments of time and money to improve the processes, infrastructure and training around cool-chain handling.
The global COVID-19 vaccine deployment that began more than a year ago has put that preparation to the test, and airfreight has met the challenges those shipments presented. However, the industry is still coping with a global capacity shortage and countries continue to adjust border regulations due to pandemic lockdowns, making planning even more difficult. Still, the industry continues to look to the future, investing in technology and needed infrastructure updates to prepare for the expected ongoing growth for increasingly complex pharmaceutical products, as well as other types of perishable cargo, including fresh produce, flowers and seafood.
In this final installment in the Air Cargo World 2021 series, executives from leading airfreight operators discuss how they have adapted to capacity shortages to continue safely moving perishable and pharmaceutical cargo; the impact of modal shifts between ocean, air and road on pharma supply chains; ongoing and future cool-chain technology improvements; and more.
Executive Vice President of Pharma & Healthcare
Global Head of Pharmaceutical Logistics
Air France KLM Martinair Cargo
Chief Commercial Officer